The Perennial Allergen Profile is a panel of allergen-specific immunoglobulin E (IgE) antibody measurements directed against allergens present year-round, including dust mites (Dermatophagoides pteronyssinus and D. farinae), cockroach, cat and dog dander, and mold species such as Aspergillus and Alternaria. This panel is used to identify sensitization to indoor and perennial environmental allergens that may drive chronic allergic rhinitis, asthma, atopic dermatitis, and allergic conjunctivitis. Identifying specific sensitization patterns guides allergen avoidance counseling, pharmacotherapy selection, and eligibility for allergen immunotherapy. Upon initial allergen exposure in a genetically susceptible individual, antigen-presenting cells activate Th2 lymphocytes, which drive B-cell class switching to produce allergen-specific IgE antibodies that bind to high-affinity FcεRI receptors on mast cells and basophils. On re-exposure, cross-linking of receptor-bound IgE by the specific allergen triggers degranulation and release of histamine, leukotrienes, prostaglandins, and cytokines, producing the immediate hypersensitivity response. Chronic perennial allergen exposure sustains this Th2-skewed immune milieu, contributing to persistent airway and mucosal inflammation.
This blood test checks whether your immune system has made allergy antibodies against common year-round allergens like dust mites, pet dander, cockroach, and mold. A positive result means your immune system is sensitized to that allergen, which—combined with your symptoms—can help your doctor identify what is triggering your allergies and plan the best treatment.
When elevated: Elevated allergen-specific IgE levels indicate immunologic sensitization and, when correlated with relevant symptoms and exposure, support a diagnosis of IgE-mediated allergic disease to the identified perennial allergen(s). Higher class levels (Class 3–6, ≥3.51 kUA/L) are associated with greater likelihood of clinical reactivity and may predict more severe or persistent allergic symptoms. Polysensitization to multiple perennial allergens is associated with more difficult-to-control asthma and rhinitis and may influence the complexity and duration of allergen immunotherapy. When low: Low or undetectable allergen-specific IgE (Class 0–1) to perennial allergens suggests that IgE-mediated sensitization to those allergens is unlikely to be driving the patient's symptoms. Non-IgE-mediated mechanisms (e.g., non-allergic rhinitis, irritant responses, mixed eosinophilic inflammation) should be considered in symptomatic patients with negative panels. A negative perennial panel does not exclude sensitization to seasonal or occupational allergens not included in the panel.
Perennial allergen sensitization can impair recovery and performance by driving chronic airway inflammation, sleep disruption, and persistent nasal congestion—all detrimental to aerobic capacity and training consistency. Athletes with documented sensitization benefit from targeted avoidance strategies and medical management to optimize breathing mechanics and sleep quality during heavy training phases.
Fasting Required
No
Order online
Choose your lab and check out. We send your lab requisition automatically — no doctor visit needed.
Get your sample collected
Visit a lab service center near you for a quick blood draw (or book at-home phlebotomy where available).
See your results
Your results land in your Insider portal, ready to review and act on — that easy.
Your price
$140.00$420
3.0× less than retail
Versus the typical direct-to-consumer retail price for this test (illustrative — consumer prices vary by provider and region).
$140.00
Peer-reviewed sources supporting the educational content on this page.